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Purpose: By acutely enhancing the arterial leg inflow, intermittent pneumatic leg compression (IPC) improves the walking
ability, arterial hemodynamics, and quality of life of claudicants. We quantified the duration of acute leg inflow enhancement
with IPC of the foot (IPCfoot), calf (IPCcalf), or both (IPCfootcalf) and its amplitude decay in claudicants and controls in
relation to the pulsatility index, an estimate of peripheral resistance. These findings are cross-correlatedwith the features of the
three implicated physiologic mechanisms: (1) an increase in the arteriovenous pressure gradient, (2) suspension of peripheral
sympathetic autoregulation, and (3) enhanced release of nitric oxide with flow and shear-stress increase.
Methods: Twenty-six limbs of 24 claudicants with superficial femoral artery occlusion or stenoses (>75%) and 24 limbs of
20 healthy controls matched for age and sex, meeting stringent selection criteria, had their popliteal volume flow and
pulsating index (peak-to-peak velocity/mean velocity) measured with duplex scanning at rest and upon delivery of IPC.
Spectral waveformswere analyzed for 50 seconds after IPCdelivery per 5-second segments. The three IPCmodeswere applied
in a true crossover design. Data analysis was performed with the Page, Friedman, Wilcoxon, Mann-Whitney and 2 tests.
Results: The median duration of flow enhancement in claudicants exceeded 50 seconds with IPCfoot, IPCcalf, and
IPCfootcalf but was shorter (P < .001) in the controls (32.5 to 40 seconds). Among the three IPC modes, the duration
of flow enhancement differed (P < .05) only between IPCfoot and IPCfootcalf. After reaching its peak within 5 seconds
of IPC, flow enhancement decayed at rates decreasing over time (trend, P < .05, Page test), which in both groups were
highest at 5 to 20 seconds, moderate at 20 to 35 seconds, and lowest at 35 to 50 seconds (P < .05, Friedman test).
Baseline and peak flow with all IPC modes was similar between the two groups. Pulsatility index attenuation in
claudicating limbs lasted a median 32.5 seconds with IPCfoot, 37.5 seconds with IPCcalf, and 40 seconds with IPCfootcalf;
duration of pulsatility index attenuation was shorter in the control limbs with IPCfoot (30 seconds), IPCcalf (32.5
seconds), or IPCfootcalf (35 seconds), yet differences, as well as those among the 3 IPC modes, were not significant.
Conclusion: Leg inflow enhancement with IPC exceeds 50 seconds in claudicants and lasts 32.5 to 40 seconds in the
controls. Peak flow occurs concurrently with maximal pulsatility index attenuation, within 5 seconds of IPC. Irrespective
of group or IPC mode, the decay rate (%) of flow enhancement is highest within 5 to 20 seconds of IPC, moderate at 20
to 35 seconds, and lowest at 35 to 50 seconds. Since attenuation in peripheral resistance terminates with the mid time
period (20 to 35 seconds) of flow decay, and nitric oxide has a half-life of<7 to 10 seconds, the study’s data indicate that
all implicated physiologic mechanisms (1, 2, and 3) are likely active immediately after IPC delivery (0 to 20 sec) and all
but nitric oxide are effective in the mid time period (20 to 35 seconds). As the pulsatility index has returned to baseline,
the late phase of flow enhancement (35 to 50 seconds) could be attributable to the declining arteriovenous pressure
gradient alone. (J Vasc Surg 2005;42:717-25.)Intermittent pneumatic compression (IPC) of the
lower limb is a well-documented method of acute arterial
leg inflow enhancement in patients with peripheral arterial
disease (PAD).1-8 Over the past 5 years, attention has been
focused on the potential role that IPC may hold in the
treatment of arterial claudication.9-11 According to the first
clinical outcomes study released in 2000,9 patients with
stable claudication (n  25) who received IPC of the foot
(IPCfoot) (4 h/day; 4.5 months) and aspirin (75 mg/
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doi:10.1016/j.jvs.2005.06.004day) while exercising unsupervised improved the median
initial and absolute claudication distances by100% and
increased the resting and postexercise ankle-brachial in-
dices by 18% and 110%, respectively (all, P  .001),
whereas their control counterparts, who had the same
treatment except IPC, did not improve their perfor-
mance.9 Randomized controlled data confirm that IPC
delivered to the foot and calf (IPCfootcalf) for 3 to 5
months (2.5 h/day) may indeed ameliorate claudica-
tion while improving arterial hemodynamics.10,11 In
light of the increase in the ankle-brachial indices of
treated legs, it has been suggested that the prolonged
arterial flow enhancement with IPC treatment may pro-
mote the development of collateral circulation.9-11
Upon IPC application, the arterial leg inflow increases
acutely twofold to threefold in claudicants and threefold to
fourfold in healthy individuals.2-7 This flow enhancement is
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nous pressure in the dependent limb decreases with IPC,
the arteriovenous pressure gradient rises inversely, causing
arterial leg inflow to increase.1-8,12 At the same time,
venous pressure attenuation with IPC also causes a tran-
sient abolition of peripheral sympathetic autoregulation by
way of the axon venoarteriolar reflex, which normally up-
regulates the arterial tone and resistance to flow on depen-
dency, protecting the microvasculature and interstitial tis-
sues from hypertension.13-18 The acute arterial leg inflow
enhancement thus generated with IPC instigates further
release of nitric oxide in response to an increase in shear-
stress, which in turn causes further attenuation in peripheral
resistance and, thus, a reciprocal arterial flow enhance-
ment.1-8,19,20 In light of the half-life of endothelium-
derived vasodilatory nitric oxide being 7 to 10 seconds,21
and venous refill occurring30 to 50 seconds in limbs with
venous valvular competence,11,22,23 determination of the
decay of the arterial leg inflow enhancement after impulse
delivery may offer an insight into the morphology of this
hemodynamic phenomenon and the sequence of physio-
logic mechanisms that permeate its occurrence.
The aim of this study was to determine the duration
and the amplitude decay of the acute leg inflow enhance-
ment with the delivery of IPC to the foot, calf, and both
combined among patients with arterial claudication and
healthy controls in relation to the flow pulsatility index, a
noninvasive measure of peripheral arterial resistance.24,25
The study findings are critically cross-correlated with the
features of the physiologic mechanisms implicated in this
phenomenon, with the purpose of shedding light on the
sequence of events that permeate the acute arterial leg
inflow enhancement with IPC that remain poorly under-
stood to date.
METHODS
Design. This is a cross-sectional study that was con-
ducted prospectively after ethics committee approval and
informed consent of the involved subjects.
Inclusion criteria. Patients with a history of PAD and
intermittent claudication due to superficial femoral artery
Table 1. Demographics, risk factors and ankle-brachial pr
Group 1 (claudicants)
Subjects 22
Age, median (range) 63 (50–77)
Female/male ratio 9/13
Diabetes mellitus 5
Smoking 4
Hypertension 8
r-ABI, median (IQR) 0.6 (0.42–0.84)
p-eABI, median (IQR) 0.28 (0.16–0.52)
Legs 26
r-ABI, Resting ankle-brachial pressure index; p-eABI, postexercise ankle-br
*Mann-Whitney test.
†2 test.occlusion or severe stenosis (75%) were considered forinclusion in the group of claudicants (group 1). Individuals
without a history of cardiovascular disease and claudication
were considered for inclusion in the group of control
subjects (group 2).
Exclusion criteria. Excluded from the study were
subjects with symptomatic chronic venous disease, CEAP
clinical classes 2 to 6, hemodynamically significant (50%
diameter stenosis) aortoiliac disease on duplex sonography
(3 months), congestive cardiac failure, recent (12
months) axial deep vein thrombosis, leg edema, wounds or
infection, diabetes mellitus of4 years duration, peripheral
sensory impairment clinically, popliteal artery occlusion or
severe atherosclerosis on duplex examination, and those on
vasoactive medication.
Subjects. The study comprised 26 limbs (22 patients)
with intermittent claudication (group 1) and 24 control
limbs (20 subjects) with normal circulation (group 2). The
two groups were matched for age and sex. Summarized in
Table I are the demographics of study subjects.
Leg inflow investigation. Arterial leg inflow was ex-
amined in the popliteal artery with real-time gated Doppler
sonography and real-time B-mode imaging, used simulta-
neously (Sonos 2500, 7.5/5.5 MHz linear array probe,
Hewlett Packard, Palo Alto, Calif). Spectral velocity data
were obtained at a 60o insonation angle with the sample
volume gate encompassing the entire lumen of the vessel.
Doppler waveforms were enveloped automatically using
dedicated software for flow estimation. Data included the
determination of volume flow, calculated from the mean
velocity multiplied by the cross-sectional area of the popli-
teal artery (mean velocity    [diameter/2]2), and the
flow pulsatility index (peak-to-peak velocity/mean veloc-
ity), a measure of peripheral resistance to flow. Mean veloc-
ity is the time average of the mean velocities of each of the
Doppler spectra occurring during an interval of 5 seconds.
Similarly, pulsatility index measurements represent values
retrieved during the same (5-second) time periods. Spectral
waveforms containing aliasing or noise due to venous flow
or wall motion were discarded and measurements were
repeated. The cross-sectional area of the popliteal artery
was calculated from its diameter obtained by viewing the
e indices of investigated subjects in the two study groups
Group 2 (controls) Statistical significance
20 —
61 (44–78) NS*
7/13 NS†
3 NS†
5 NS†
6 NS†
1.0 P  .0001*
1.0 P  .0001*
24 —
pressure index; IQR, interquartile range.essur
achialartery longitudinally and by placing the tracker ball-guided
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and far walls; 10 measurements were taken, and the average
value was used for calculating the volume flow.
Study protocol. Three IPC modes were investigated
in the current study: IPCfoot, IPCcalf, and IPCfootcalf.
Investigation of the subjects was preceded by a resting
period of 30 minutes. Popliteal flow was determined at rest
in the sitting position (three different readings). IPC was
then applied for 5 minutes in the same position. Spectral
data were monitored with continuous duplex scanning, but
their registration and storage in the hard-drive memory of
the system’s computer commenced with the delivery of the
last pneumatic impulse, through a time period of 50 sec-
onds. Spectral information was then analyzed by dividing
the stored Doppler signal into a sequence of 5-second
segments.
After a 10-minute resting period, flow was obtained
again. The second IPCmode of the three that were studied
was applied for 5 minutes, and the spectral information of
flow velocities from the delivery of the last impulse was
stored and processed as previously described. The same
procedure was followed for the investigation of the third
IPC mode.
All measurements were obtained by the same examiner
in temperature-controlled conditions (21° to 23°C). The
reproducibility of flow velocity measurements obtained
with the above method has been reported.4
Designation of IPC sequence. The sequence of IPC
modes in the examination protocol of the study was subject
to a true crossover design, aiming at eliminating the possi-
bility of carry-over effects. Implemented evenly, the follow-
ing sequences of IPC modes were examined: (1) IPCfoot-
IPCcalf-IPCfootcalf, (2) IPCfoot-IPCfootcalf-IPCcalf, (3)
IPCcalf-IPCfoot-IPCfootcalf, (4) IPCcalf-IPCfootcalf-IPC-
calf, (5) IPCfootcalf-IPCfoot-IPCcalf, and (6) IPCfootcalf-
IPCcalf-IPCfoot. In both groups, every new entry was allot-
ted a sequence in this order.
Definitions and calculations. Duration of volume
flow enhancement in each one of the examined limbs was
defined as the time-period that volume flow remained
higher than baseline. This time, expressed as median and
interquartile range, enabled inter- and intragroup compar-
isons. Duration of flow pulsatility index attenuation in each
one of the examined limbs was defined as the time during
which the pulsatility index remained lower than baseline.
The percentage rate (%) of volume flow decay for each one
of the 5-second time segments after delivery of IPC, ad-
justed for the amplitude of volume flow enhancement, was
defined as ([volume flow at ttime – volume flow at ttime 5
seconds]  100/volume flow at ttime).
IPC equipment. IPCfoot, IPCcalf and IPCfootcalf
were delivered with the Art-Assist 1000 (ACI-Medical, San
Marcos, Calif) at the following presets: three impulses per
minute, inflation pressure, 120 mm Hg; impulse rise time,
0.5 to 0.6 seconds; impulse duration, 4 seconds; deflation
pressure, 0 mm Hg; deflation time, 16 seconds.
Analysis and statistics. Intragroup statistical analysis
of paired volume flow and pulsatility index data was per-formed with the Wilcoxon signed ranks test. Intergroup
differences in the volume flow and pulsatility index were
evaluated with the Mann-Whitney test. The estimated me-
dian (EM), point estimate (PE), and the 95% confidence
interval (CI) were calculated but are quoted selectively for
data presentation simplicity. The Bonferroni correction was
applied when appropriate.26 The Page test of ordered alter-
natives was used for examining the percentage rate of
volume flow decay for “trend-over-time” after delivery of
IPC. Differences in the percentage rates of volume flow
decay after IPC delivery were evaluated with the Fried-
man’s two-way analysis of variance. Differences in propor-
tions were assessed with the 2 test. P .05 was considered
significant. Results are expressed as median and interquar-
tile range (IQR), unless otherwise stated.
Fig 1. Duration (median and interquartile range) of (A) volume
flow enhancement and (B) flow pulsatility index attenuation in the
popliteal artery of 26 limbs of claudicants (group 1, shaded bars)
and 24 normal control limbs (group 2, white bars) with intermit-
tent pneumatic compression (IPC) of the foot (IPCfoot), calf
(IPC ) and both combined (IPC ); statistical analysis incalf footcalf
the Results section.
n.
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Duration of volume flow enhancement. Themedian
duration of volume flow enhancement in the popliteal
Fig 2. Volume flow enhancement and decay (median an
compression (IPC) in the popliteal artery of (A) 26 limb
subjects (group 2); statistical analysis in the Results sectioartery with IPCfoot, IPCcalf and IPCfootcalf, (Fig 1, A) waslonger in claudicants (P  .001) than in the limbs of
controls; in both groups, the duration of enhancement was
longer with IPCfootcalf than IPCfoot (P  .05); however,
differences were small between IPCfoot and IPCcalf as well
erquartile range) after delivery of intermittent pneumatic
laudicants (group 1) and (B) 24 limbs of healthy controld int
s of cas between IPCcalf and IPCfootcalf (P  .096).
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after the peak volume flow was reached within 5 seconds of
IPC delivery (P  .001), the volume flow declined steeply
(Fig 2, A). Cumulatively, volume flow in claudicants re-
mained higher than baseline in the 45- to 50-second time
period with IPCfootcalf and IPCcalf (P  .009) and re-
mained higher than baseline for 45 seconds with IPCfoot
(P  .035).
The percentage rates of volume flow decay, determined
at nine consecutive time segments lasting 5 seconds each,
from the 5th to the 50th second after impulse delivery, had
a significant declining “trend-over-time” (Page test) with
IPCfoot (P .05), IPCcalf (P .05), and IPCfootcalf (P
.05) (Fig 3, A). Based on their magnitude, the volume flow
decay rates were stratified in three time periods: 5 to 20
seconds, 20 to 35 seconds, and 35 to 50 seconds from
impulse delivery (Table II); differences in the percentage
rates (in both the median and the mean) among these time
periods were statistically significant for IPCfoot, IPCcalf, and
IPCfootcalf (P  .01 by Friedman test). Peak volume flow
with IPCfootcalf was significantly higher than with IPCcalf
(P .001) and IPCfoot (P .001). Also, peak volume flow
with IPCcalf was higher than with IPCfoot (P  .001).
Decay of volume flow in controls. Similar to the
Fig 3. Rates of decay (median and interquartile range) of volume
flow enhancement in the popliteal artery after delivery of intermit-
tent pneumatic compression (IPC) of the foot (IPCfoot), calf
(IPCcalf), and both (IPCfootcalf) in (A) 26 limbs of claudicants
(group 1) and (B) 24 limbs of normal control subjects (group 2)
were significant for “trend-over-time” (P  .05; Page test).decay of volume flow enhancement in claudicants, volumeflow declined rapidly after its peak was reached within 5
seconds of the delivery of IPCfootcalf, IPCcalf, and IPCfoot
(P  .001) (Fig 2, B). Volume flow remained significantly
higher than baseline for 45 seconds with IPCfootcalf (P 
.014) and IPCcalf (P  .04), and for 40 seconds with
IPCfoot (P  .022). The percentage rates of volume flow
decay, determined at nine consecutive time segments last-
ing 5 seconds each, from the 5th to the 50th second after
impulse delivery, had a significant declining “trend-over-
time” (Page test) with IPCfoot (P .05), IPCcalf (P  .05),
and IPCfootcalf (P  .05) (Fig 3, B). Based on their
magnitude, the percentage rates of volume flow decay were
stratified in three time periods: 5 to 20 seconds, 20 to 35
seconds, and 35 to 50 seconds from impulse delivery (Table
II). Differences in the percentage rates (in both the median
and the mean) among these time periods were statistically
significant for IPCfoot (P  .01), IPCcalf (P  .02), and
IPCfootcalf (P .05) (Friedman’s test). Peak volume flow
with IPCfootcalf was significantly higher than with IPCcalf
(P .001) and IPCfoot (P .001). Also, peak volume flow
with IPCcalf was higher than with IPCfoot (P  .001).
Claudicants vs controls. Baseline volume flow (on
sitting) was higher in claudicants without reaching signifi-
cance (P  .4; PE, 6.24 mL/min; 95%CI, 21.6 to –9.74
mL/min). Peak volume flowwith any IPC mode applied was
not significantly different between the study groups (P.2).
Duration of pulsatility index attenuation. The du-
ration of pulsatility index attenuation in groups 1 and 2 is
depicted in Fig 1, B. The median duration was longer in the
limbs of claudicants with any of the three IPC modes;
however, significance was not reached (all, P .29). Simi-
larly, the duration of pulsatility index attenuation was not
significantly different among the three IPC modes in both
study groups (all, P  .8).
Decay of pulsatility index in claudicants. Immediately
after the pulsatility index reached its maximum attenuation,
within 5 seconds of the delivery of IPCfootcalf, IPCcalf, and
IPCfoot (P .001), its return to baseline was noted (Fig 4,
A). The pulsatility index remained attenuated for 35 sec-
onds after the delivery of IPCfootcalf (P .003), IPCcalf (P
 .048; EMD, –.27; 95% CI, 0 to –.5) and IPCfoot (P 
.04; EMD, –.24; 95% CI, 0 to –.5). Similar to previous
reports, the pulsatility index with IPCfoot was less attenu-
ated (P  .001) than with IPCcalf and IPCfootcalf. Pulsa-
tility index attenuation with IPCfootcalf was similar to that
with IPCcalf (P  .06; EMD, –.1; 95 %CI, –.2 to .005).
Decay of pulsatility index in controls. The decay of
pulsatility index attenuation in the control limbs commenced
immediately after its peak had been reached within 5 seconds
of the delivery of IPCfootcalf, IPCcalf, and IPCfoot (P .001)
(Fig 4, B). Cumulatively, the pulsatility index in the control
limbs remained significantly attenuated for 35 seconds after
delivery of IPCfootcalf (P  .003), for 30 seconds with
IPCcalf (P  .001), and for 30 seconds with IPCfoot (P 
.002). The pulsatility index with IPCfootcalf was lower
than with IPCcalf (P  .006) and IPCfoot (P  .001). The
pulsatility index with IPCcalf was also lower than that with
IPCfoot (P  .003).
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lower in the limbs of claudicants than the control, at
baseline, at 5 seconds after IPC delivery, and throughout
the period (5 to 50 sec) of its determination with IPC (P
.0001).
DISCUSSION
The current study examined the decay of acute volume
flow enhancement with IPC of the foot, calf, and both
combined in claudicants and determined its duration in
comparison with healthy subjects. Cross-correlation of vol-
ume flow with pulsatility index, an estimate of peripheral
resistance,24,25 offered an insight into the sequence of
physiologic mechanisms empowering flow enhancement
with IPC. The study data have demonstrated that the
median arterial leg inflow enhancement with IPC is a brief
occurrence that exceeds 50 seconds in claudicants and lasts
30 to 40 seconds in healthy limbs, depending on the IPC
mode. The difference in duration between the two groups,
although small, was consistent and statistically significant.
Flow enhancement in both groups was also longer with
IPCfootcalf than IPCfoot.
The decay rates of volume flow enhancement in the
limbs of both study groups, adjusted for volume flow
amplitude, demonstrated a significant declining “trend-
over-time” (Page test). Analysis of the decay rates based on
their amplitude (Friedman’s test) enabled stratification in
three phases. In the early phase, commencing with peak
flow at 5 seconds through 20 seconds, the decay rates of
volume flow enhancement are highest. At the same time,
the pulsatility index, having also reached its maximum
attenuation within 5 seconds of IPC delivery, increased
rapidly. Volume flow continued to decline in the middle
phase of flow enhancement (20 to 35 seconds), but the rate
of decay was significantly lower, while the pulsatility index
continued to rise. In the third phase of flow enhancement
(35 to 50 seconds), its decay slowed further or leveled,
while the attenuation of the pulsatility index had already
been exhausted.
Further, to the increase in the arteriovenous pressure
Table II. Mean and median decay rates of volume flow en
50 seconds from the delivery of intermittent pneumatic co
Time after
IPC
5-20 seconds 20-35
Mean Median Mean
Claudicants
IPCfoot 7.6 (4.8-10.7) 7.1 (4.7-11) 4.6 (1.8-5.6)
IPCcalf 12 (8.5-16.6) 10.8 (7.5-16.7) 8.9 (5.2-11.2
IPCfootcalf 11.1 (7.6-15.3) 10.5 (6.9-14) 8.6 (6.1-12.5
Control
IPCfoot 12.6 (8.6-16.2) 12 (8.7-15.1) 9.9 (5.8-14.6
IPCcalf 17.7 (12.3-22.2) 15.8 (11.2-21.6) 13.2 (11-16.4
IPCfootcalf 18.3 (12.9-24.7) 16.9 (13.7-27.7) 12.3 (8.7-17.5
IPC, Intermittent pneumatic compression.
*Decay rates derive from the original data of depicted in Fig. 3, A and B an
among these periods are statistically significant.gradient, the volume flow enhancement with IPC is alsothe product of a sequence of compensatory re-adjustments
in the arterial circulation resulting in the attenuation of
peripheral resistance to flow.1-10,18 The latter is supported
by the highly significant, concurrent, but mirror-image
decay curves of volume flow and pulsatility index after IPC
delivery.1-8,18 The study’s finding that the pulsatility index
reaches maximum attenuation within 5 seconds of IPC,
when peak volume flow is sustained, commencing its return
to baseline concurrently with the latter, highlights the
immediate optimal, yet short-lived, attenuation of periph-
eral resistance with IPC.24,25 Pulsatility index attenuation
decays in the early (5 to 20 seconds) and mid (20 to 35
seconds) phases of volume flow enhancement but is back to
baseline in the late phase (35 to 50 seconds), indicating
that, unlike the early and mid phases, flow enhancement in
the late phase is unrelated to peripheral resistance.
The arterial leg inflow enhancement with IPC in the
early phase is twofold to threefold in claudicants and two-
fold to fourfold in healthy limbs, far exceeding the level
expected by the arteriovenous pressure gradient elevation
due to venous expulsion with IPC.1-6,18 Based on Poi-
seuille’s law associating the arteriovenous pressure gradient
directly with the arterial flow, and assuming that the arterial
and venous pressures at the ankle on sitting are 130
(70[diastolic] 60 [hydrostatic]) mmHg and 60[hydrostatic] mm
Hg, respectively, elevation of this gradient with IPC (sub-
sequent to a reduction in venous pressure from 60 mmHg
to 10 mm Hg) could not cause the flow to increase by
70%.1,2,4,6,18 The fact that 30 seconds after IPC delivery
venous pressure is still lower than baseline in limbs with
normal reflux 12 supports the role of arteriovenous pressure
gradient in the late phase of flow enhancement. The level of
flow enhancement with IPC also exceeds that (80% to
100%) expected by the transient suspension of venoarter-
iolar reflex in response to IPC 13-17 underscored recently.18
The higher level of flow enhancement achieved with IPC
might be attributable to nitric oxide release with shear-
stress enhancement.1-7 Human umbilical vein endothelial
cells cultured in vitro in a system simulating vessel collapse
conditions enhanced their nitric oxide production and up-
ement at 5 to 20 seconds, 20 to 35 seconds, and 35 to
ssion in groups 1 (claudicants) and 2 (control)*
ds 35-50 seconds Friedman’s test
Median Mean Median Mean Median
(1-6.1) 0.15 (0-1.6) 0 (0-3.3) P  0.001 P  0.001
(2.8-10.7) 3.9 (0.9-7.8) 2.5 (0-6.4) P  0.001 P  0.01
(4.6-10.7) 6.9 (3-8.7) 5.3 (2-8.3) P  0.001 P  0.01
(0.6-14.8) 0 (0-4.9) 0 (0-0.3) P  0.01 P  0.001
(4.3-14.5) 2.6 (0-12.6) 0 (0-9.7) P  0.02 P  0.01
(9.7-17.7) 7.3 (0-15.7) 0 (0-11.3) P  0.05 P  0.001
expressed as median and interquartile range. Differences in the decay rateshanc
mpre
secon
4.3
) 7.3
) 5.8
) 10
) 8.5
) 12
d are regulated endothelial nitric oxide synthase messenger RNA
foot
alysis
JOURNAL OF VASCULAR SURGERY
Volume 42, Number 4 Delis and Knaggs 723expression when subjected to pulsatile flow and external
compression with a pneumatic air pump.20
Venous pressure decrease with IPC causes the arterio-
venous pressure gradient to increase and suspends the
Fig 4. Pulsatility index attenuation and its decay (media
of IPC of the foot (IPCfoot), calf (IPCcalf) and both (IPC
limbs of healthy control subjects (group 2); statistical anvenoarteriolar reflex, while acute shear stress elevation bothon the venous and arterial sides triggers the release of nitric
oxide.6,11,18-20 Among the three aforementioned physio-
logic mechanisms, the arteriovenous pressure gradient is
the obvious cause of flow enhancement from the delivery of
interquartile range) in the popliteal artery after delivery
calf) in (A) 26 limbs of claudicants (group 1) and (B) 24
in the Results section.n andIPC to the restoration of leg venous pressure.6,12,18 The
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pressure remained below its elicitation level (40 mm
Hg).17,18 Since the venous pressure on sitting is about 60
mm Hg,12 the arteriovenous pressure gradient is a flow-
enhancing mechanism outlasting the suspension of the
venoarteriolar reflex.18 The hemodynamic effects of IPC,
being most potent in the early phase (0 to 20 seconds) after
IPC delivery both on the arterial and venous sides,27 and
the short half-life (7 to 10 seconds) of nitric oxide,19-21
support the view that endothelium-dependent vasodilata-
tion would likely hold a role (if any) in the early stage of
flow enhancement.
In view of this, the study data point at a plausible
sequence of physiologic mechanisms activated with the
delivery of IPC. As volume flow enhancement and pulsatil-
ity index attenuation are both highest at the early phase (0
to 20 seconds) after IPC delivery, all three implicated
mechanisms would likely be effective at this time point,
acting in synergy. The highest decay rate of enhanced
volume flow after the 5th second of IPC delivery, amid an
increasing pulsatility index, implicates the short half-life of
nitric oxide 21 and the immediate venous refill12 resulting
in venous pressure elevation with a concomitant decrease in
the arteriovenous pressure gradient. In the middle phase,
20 to 35 seconds after IPC delivery, the declining decay
rate of volume flow, amid an increasing pulsatility index,
implicates the diminishing arteriovenous pressure gradient
and the venoarteriolar reflex,18 as the short half-life of nitric
oxide would render its effect borderline at this phase.21
Finally in the late phase, 35 to 50 seconds from IPC
delivery, the slow return of volume flow to baseline amid a
normalized pulsatility index excludes the roles of nitric
oxide and the venoarteriolar reflex in the volume flow
enhancement, implicating the declining arteriovenous
pressure gradient as the sole mechanism.12,24,25 The longer
duration of volume flow enhancement in limbs with clau-
dication, noted with all IPC modes used in the study, could
be attributable to an impairment of peripheral sympathetic
autoregulation in PAD.6,17 Although the venoarteriolar
reflex in PAD is elicited at a lower venous pressure level
than in healthy limbs, impairment of peripheral sympa-
thetic autoregulation may result in a decelerated ignition of
the axon reflex prolonging the state of resistance recov-
ery.17 The median duration of flow pulsatility index atten-
uation was longer in claudicants by 2.5 seconds, both with
IPCfoot and IPCcalf, and by 5 seconds with IPCfootcalf;
however, significance was not reached. The longer duration
of volume flow enhancement with IPCfootcalf than IPCfoot
could be explained by consideration of the three times as
much venous volume expelled with the former,27 resulting
in a longer venous refill time, a longer sustained arterio-
venous pressure gradient elevation, and venoarteriolar re-
flex suspension.
Stable claudicants randomized to receive 5 months of
IPCfootcalf treatment (2.5 hours/day) experienced an
increase in themedian initial claudication distance by 197%,
the absolute claudication distance by 212%, and the resting
and postexercise ankle-brachial indices by 17% and 64%,respectively (all, P .001), amid a significant improvement
in quality of life, when the control subjects had experienced
no significant changes.10 In light of the twofold to three-
fold arterial leg inflow enhancement and the attenuation of
peripheral resistance on IPC application, the above clinical
outcomes implicate the development of collateral circula-
tion.9-11 An increase in the pressure gradient,28 volume
flow, and flow velocity around the arterial block 29 are most
effective elements of collateralization. A single study on the
duration of hyperemia with IPC is currently available.30
Peak volume flow in the common femoral artery of 19
normal limbs on recumbency (head on pillows) subjected
to pneumatic calf and thigh impulses of 60 mm Hg, 10
seconds per minute or 60 seconds per 2 minutes increased
by 38% and 57% (median) respectively. The duration of
flow enhancement was 37 seconds and 54 seconds, respec-
tively. The effects of IPC on dependency and peripheral
resistance were not addressed.30
CONCLUSION
As the interest on the clinical efficacy of IPC in PAD
gains momentum,9-11,31-34 the current study, by quantify-
ing the acute arterial leg inflow enhancement from the
delivery of IPC to the foot or calf, or both, through to its
decay, in cross-correlation with the peripheral resistance,
offers an insight into the sequence of physiologic mecha-
nisms permeating this hemodynamic phenomenon that
exceeds 50 seconds in claudicants and lasts 30 to 40 sec-
onds in controls. The data indicate that the arteriovenous
pressure gradient, peripheral sympathetic autoregulation,
and nitric oxide are likely active after IPC delivery (0 to 20
seconds), and that all but nitric oxide are effective in the
mid phase (20 to 35 seconds) of flow enhancement. In the
absence of peripheral resistance attenuation in the late phase
(35 to 50 seconds) of flow decay, the ever-diminishing arte-
riovenous pressure gradient is the single effective flow-
enhancing mechanism in this phase.
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